Surmodics reported $13.78M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US USD 2.69B 65M
Align Technology ALGN:US USD 398.55M 27.85M
Anika Therapeutics ANIK:US USD 21.28M 8K
Arrowhead Research ARWR:US USD 32.74M 1.12M
Baxter International BAX:US USD 782M 35M
Bioscrip BIOS:US USD 142.01M 228K
Boston Scientific BSX:US USD 1.13B 33M
Cryolife CRY:US USD 36.37M 1.67M
Edap Tms EDAP:US EUR 5.46M 668K
Edwards Lifesciences EW:US USD 377.3M 31.7M
Haemonetics HAE:US USD 92.41M 762K
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Johnson & Johnson JNJ:US USD 6.09B 137M
Merit Medical Systems MMSI:US USD 89.78M 4.29M
Mesa Laboratories MLAB:US USD 21.99M 5.76M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Stryker SYK:US USD 1.48B 27M
Surmodics SRDX:US USD 13.78M 925K